Advertisement

HindustanTimes Thu,25 Dec 2014

Ranbaxy recalls 64,000 bottles of generic Lipitor in latest quality row

HT Correspondent, Hindustan Times  New Delhi, March 09, 2014
First Published: 22:57 IST(9/3/2014) | Last Updated: 22:59 IST(9/3/2014)

Reeling under a flurry of regulatory rebukes due to quality control, Ranbaxy Laboratories, has recalled around 64,000 bottles of the generic version of a cholesterol-lowering drug in the US after dosage mix-up was reported to the US health regulator.

Advertisement

Ranbaxy, India’s biggest drug maker by revenue and the majority owned by Japan’s Daiichi Sankyo, voluntarily recalled 64,626 bottles containing atorvastatin calcium (generic version of Lipitor) tablets after a US-based pharmacist found a 20-milligram tablet in a sealed bottle marked for 10-milligram tablets, said the enforcement report by the US Food and Drug Administration.

The recall happened in January, the report said. The FDA classified the recall as Class II, which signifies a remote chance of severe adverse consequences or death due to the product flaw.

Ranbaxy confirmed the recall. “We are conducting a voluntary recall in the US,” said the spokesperson. “To date, Ranbaxy has not received any product complaints related to these batches. Other lot numbers, package sizes and strengths are not affected by this.”


Advertisement
more from Business

Ajay Singh-led group to invest $217 mn in SpiceJet

A consortium of investors led by SpiceJet co-founder Ajay Singh is likely to invest $217 million (Rs 1,378 crore) to pick a substantial stake in the embattled airline, sources told HT.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved